96 related articles for article (PubMed ID: 2174230)
21. Host range mutants of adenovirus type 12 E1 defective for lytic infection, transformation, and oncogenicity.
Byrd PJ; Grand RJ; Breiding D; Williams JF; Gallimore PH
Virology; 1988 Mar; 163(1):155-65. PubMed ID: 2964753
[TBL] [Abstract][Full Text] [Related]
22. Adenovirus E1A-p105(Rb) protein interactions play a direct role in the initiation but not the maintenance of the rodent cell transformed phenotype.
Nielsch U; Fognani C; Babiss LE
Oncogene; 1991 Jun; 6(6):1031-6. PubMed ID: 2067843
[TBL] [Abstract][Full Text] [Related]
23. Efficient Transformation of Primary Human Mesenchymal Stromal Cells by Adenovirus Early Region 1 Oncogenes.
Speiseder T; Hofmann-Sieber H; Rodríguez E; Schellenberg A; Akyüz N; Dierlamm J; Spruss T; Lange C; Dobner T
J Virol; 2017 Jan; 91(1):. PubMed ID: 27795433
[TBL] [Abstract][Full Text] [Related]
24. Mitogenic activity of the adenovirus type 12 E1A gene induced by hormones in rat cells.
Oda K; Masuda-Murata M; Shiroki K; Handa H
J Virol; 1986 Apr; 58(1):125-33. PubMed ID: 2936902
[TBL] [Abstract][Full Text] [Related]
25. Role of the adenovirus early region 1B tumor antigens in transformation and lytic infection.
Bernards R; de Leeuw MG; Houweling A; van der Eb AJ
Virology; 1986 Apr; 150(1):126-39. PubMed ID: 2937199
[TBL] [Abstract][Full Text] [Related]
26. Different chemosensitivities of rat 3Y1 fibroblasts transformed by various agents in vitro.
Kido Y; Mitsudomi T; Kuwano H; Maehara Y; Sugimachi K
Anticancer Res; 1991; 11(3):1305-8. PubMed ID: 1888164
[TBL] [Abstract][Full Text] [Related]
27. Wild-type adenovirus type 5 transforming genes function as transdominant suppressors of oncogenesis in mutant adenovirus type 5 transformed rat embryo fibroblast cells.
Su ZZ; Leon JA; Jiang H; Austin VN; Zimmer SG; Fisher PB
Cancer Res; 1993 Apr; 53(8):1929-38. PubMed ID: 8385576
[TBL] [Abstract][Full Text] [Related]
28. Isolation and characterization of insertion mutants in E1A of adenovirus type 5.
Bautista DS; Hitt M; McGrory J; Graham FL
Virology; 1991 Jun; 182(2):578-96. PubMed ID: 1827228
[TBL] [Abstract][Full Text] [Related]
29. Adenovirus type 12 E1B 19-kilodalton protein is not required for oncogenic transformation in rats.
Edbauer C; Lamberti C; Tong J; Williams J
J Virol; 1988 Sep; 62(9):3265-73. PubMed ID: 2969983
[TBL] [Abstract][Full Text] [Related]
30. Independent transformation activity by adenovirus-5 E1A-conserved regions 1 or 2 mutants.
Svensson C; Bondesson M; Nyberg E; Linder S; Jones N; Akusjärvi G
Virology; 1991 Jun; 182(2):553-61. PubMed ID: 1827227
[TBL] [Abstract][Full Text] [Related]
31. An ovine adenovirus vector lacks transforming ability in cells that are transformed by AD5 E1A/B sequences.
Xu ZZ; Nevels M; MacAvoy ES; Lockett LJ; Curiel D; Dobner T; Both GW
Virology; 2000 Apr; 270(1):162-72. PubMed ID: 10772988
[TBL] [Abstract][Full Text] [Related]
32. Induction of syncytia by neuropathogenic murine leukemia viruses depends on receptor density, host cell determinants, and the intrinsic fusion potential of envelope protein.
Chung M; Kizhatil K; Albritton LM; Gaulton GN
J Virol; 1999 Nov; 73(11):9377-85. PubMed ID: 10516046
[TBL] [Abstract][Full Text] [Related]
33. Functional domains of adenovirus type 5 E1a proteins.
Lillie JW; Loewenstein PM; Green MR; Green M
Cell; 1987 Sep; 50(7):1091-100. PubMed ID: 2957064
[TBL] [Abstract][Full Text] [Related]
34. Expression of region E1b of human adenoviruses in the absence of region E1a is not sufficient for complete transformation.
Van den Elsen P; Houweling A; Van der Eb A
Virology; 1983 Jul; 128(2):377-90. PubMed ID: 6310863
[TBL] [Abstract][Full Text] [Related]
35. Different adenovirus E1A-controlled properties of transformed cells require different levels of E1A expression.
Vaessen RT; Houweling A; van der Eb AJ
Gene; 1987; 54(2-3):247-54. PubMed ID: 2820846
[TBL] [Abstract][Full Text] [Related]
36. N-Linked glycosylation is required for XC cell-specific syncytium formation by the R peptide-containing envelope protein of ecotropic murine leukemia viruses.
Kubo Y; Ishimoto A; Amanuma H
J Virol; 2003 Jul; 77(13):7510-6. PubMed ID: 12805451
[TBL] [Abstract][Full Text] [Related]
37. E1A products of adenoviruses reduce the expression of cellular proliferation-associated genes.
Timmers HT; De Wit D; Bos JL; Van der Eb AJ
Oncogene Res; 1988; 3(1):67-76. PubMed ID: 2974528
[TBL] [Abstract][Full Text] [Related]
38. Definition of a region required for transformation in E1a of adenovirus 12.
Murphy M; Opalka B; Sajaczkowski R; Schulte-Holthausen H
Virology; 1987 Jul; 159(1):49-56. PubMed ID: 2955566
[TBL] [Abstract][Full Text] [Related]
39. Drug-induced revertants of adenovirus-transformed cells: retransformation by 5-azacytidine without reactivation of E1a.
Weber JM; Sircar S; Fleurent J; Hamel M
J Gen Virol; 1990 Mar; 71 ( Pt 3)():585-91. PubMed ID: 1690260
[TBL] [Abstract][Full Text] [Related]
40. Tumorigenicity of adenovirus-transformed cells: region E1A of adenovirus 12 confers resistance to natural killer cells.
Sawada Y; Föhring B; Shenk TE; Raska K
Virology; 1985 Dec; 147(2):413-21. PubMed ID: 3878030
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
